Faculty

Aruna Kamineni

Clinical Assistant Professor, Epidemiology


Education

PhD Epidemiology, University of Washington, 2010
MPH Epidemiology, University of Washington, 1997

Contact


WA

Bio

Aruna Kamineni, PhD, MPH, has expertise in using case-control methods to evaluate screening efficacy, and her research focuses on addressing evidence gaps for clinical guidelines, particularly for cervical and colorectal cancer prevention. A substantial portion of her work has focused on developing infrastructure and methods for research using electronic clinical and administrative health care data.

Since 2011, Dr. Kamineni has participated in the National Cancer Institute’s Population-based Research to Optimize the Screening Process (PROSPR) consortium to evaluate and improve cancer screening in U.S. community settings. As a principal investigator for multisite cervical and colorectal cancer PROSPR Research Centers, Dr. Kamineni is leading and collaborating on work to determine how to optimally use screening tests and consider how to tailor screening for population subgroups.

Dr. Kamineni’s research goals include studying the impact of human papillomavirus (HPV) DNA testing and HPV vaccination on cervical cancer and screening programs. Multidisciplinary collaboration is a valued and important driver of Dr. Kamineni’s research and she embraces a team science approach to optimizing cancer prevention.

Recent Publications (PubMed)

Validation of human immunodeficiency virus diagnosis codes among women enrollees of a U.S. health plan.
(2024 Feb 22)
BMC Health Serv Res 24(1): 234
Pocobelli G, Oliver M, Albertson-Junkans L, Gundersen G, Kamineni A

Predicting Risk of Colorectal Cancer After Adenoma Removal in a Large, Community-based Setting.
(2024 Feb 14)
Am J Gastroenterol
Lee JK, Jensen CD, Udaltsova N, Zheng Y, Levin TR, Chubak J, Kamineni A, Halm EA, Skinner CS, Schottinger JE, Ghai NR, Burnett-Hartman A, Issaka R, Corley DA

SARS-CoV-2 Infection and Related Hospitalization among Cancer Survivors.
(2024 Mar 1)
Cancer Epidemiol Biomarkers Prev 33(3): 442-444
White LL, Burnett-Hartman AN, Ichikawa LE, Goldberg SR, Chubak J, Spencer Feigelson H, Kamineni A

Timing of Colposcopy and Risk of Cervical Cancer.
(2023 Nov 1)
Obstet Gynecol 142(5): 1125-1134
Alimena S, Lykken JM, Tiro JA, Chubak J, Kamineni A, Haas JS, Werner C, Kobrin SC, Feldman S

Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning One Year after a Negative Fecal Occult Blood Test, among Screen-Eligible 76- to 85-Year-Olds.
(2023 Oct 2)
Cancer Epidemiol Biomarkers Prev 32(10): 1382-1390
Dalmat RR, Ziebell RA, Kamineni A, Phipps AI, Weiss NS, Breslau ES, Burnett-Hartman AN, Corley DA, Doria-Rose VP, Green BB, Halm EA, Levin TR, Schottinger JE, Chubak J

Show complete publication list

In the News

No news articles at this time.